Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Mitophagy-dependent macrophage reprogramming protects against kidney fibrosis
Divya Bhatia, Kuei-Pin Chung, Kiichi Nakahira, Edwin Patino, Michelle C. Rice, Lisa K. Torres, Thangamani Muthukumar, Augustine M.K. Choi, Oleh M. Akchurin, Mary E. Choi
Divya Bhatia, Kuei-Pin Chung, Kiichi Nakahira, Edwin Patino, Michelle C. Rice, Lisa K. Torres, Thangamani Muthukumar, Augustine M.K. Choi, Oleh M. Akchurin, Mary E. Choi
View: Text | PDF
Research Article Nephrology

Mitophagy-dependent macrophage reprogramming protects against kidney fibrosis

  • Text
  • PDF
Abstract

Mitophagy, by maintaining mitochondrial quality control, plays a key role in maintaining kidney function and is impaired in pathologic states. Macrophages are well known for their pathogenic role in kidney fibrosis. Here, we report that PINK1/Parkin-mediated mitophagy in macrophages is compromised in experimental and human kidney fibrosis. We demonstrate downregulation of mitophagy regulators mitofusin-2 (MFN2) and Parkin downstream of PINK1 in kidney fibrosis. Loss of either Pink1 or Prkn promoted renal extracellular matrix accumulation and frequency of profibrotic/M2 macrophages. Pink1–/– or Prkn–/– BM-derived macrophages (BMDMs) showed enhanced expression of rictor. Mitochondria from TGF-β1–treated Pink1–/– BMDMs exhibited increased superoxide levels, along with reduced respiration and ATP production. In addition, mitophagy in macrophages involves PINK1-mediated phosphorylation of downstream MFN2, MFN2-facilitated recruitment of Parkin to damaged mitochondria, and macrophage-specific deletion of Mfn2 aggravates kidney fibrosis. Moreover, mitophagy regulators were downregulated in human CKD kidney and TGF-β1–treated human renal macrophages, whereas Mdivi1 treatment suppressed mitophagy mediators and promoted fibrotic response. Taken together, our study is the first to our knowledge to demonstrate that macrophage mitophagy plays a protective role against kidney fibrosis via regulating the PINK1/MFN2/Parkin-mediated pathway.

Authors

Divya Bhatia, Kuei-Pin Chung, Kiichi Nakahira, Edwin Patino, Michelle C. Rice, Lisa K. Torres, Thangamani Muthukumar, Augustine M.K. Choi, Oleh M. Akchurin, Mary E. Choi

×

Figure 5

Macrophage PINK1-mediated mitophagy is suppressed during fibrotic conditions.

Options: View larger image (or click on image) Download as PowerPoint
Macrophage PINK1-mediated mitophagy is suppressed during fibrotic condit...
(A) Western blot and densitometry analysis for PINK1 expression normalized to β-actin in THP-1–derived human macrophages cultured in the absence (–) or presence (+) of TGF-β1 (5 ng/mL) for 48 hours (n = 5 per group). (B) Western blot and densitometry analysis for MFN2 and Parkin normalized to GAPDH in renal macrophages isolated from WT mice 7 days after sham or UUO surgery (n = 3 per group). (C) Western blot and densitometry analysis for MFN2 and Parkin normalized to TIM23 in mitochondrial lysates from BMDMs (n = 4 per group) cultured in the absence (–) or presence (+) of TGF-β1 (5 ng/mL) for 48 hours. β-Actin (a cytosolic marker) was used to confirm the purity of mitochondrial fractions. (D and E) Representative confocal microscopy images (D) and quantification of mitochondria colocalized with LC3 (E). Pink1+/+ and Pink1–/– BMDMs cultured in absence or presence of TGF-β1 were analyzed using MitoTracker (red) dye, anti-LC3 (green), and Hoechst (blue) dye. White arrows indicate colocalization of LC3 with mitochondria. Over 100 cells from 6 random fields per experimental group, each in triplicate, were analyzed using ImageJ. Scale bar: 10 mm. (F) Mitophagy assessment in Pink1+/+ and Pink1–/– F4/80+ renal macrophages from mice fed with control (Ctl, n = 5 per group) or adenine (AD, n = 7 per group) diet for 28 days and stained with MitoTracker and LysoTracker dyes using flow cytometry. (G) Mitophagy assessment in Pink1+/+ and Pink1–/– BMDMs (n = 3 per group) cultured in the absence or presence of TGF-β1 (5 ng/mL) for 48 hours using flow cytometry. (H) Representative histograms for the detection of mitophagy showing the lyso dye–labeled positive lysosomes gated for Mtphagy dye–stained mitochondria. Data are mean ± SEM representative of 3 independent experiments and analyzed by Student’s unpaired 2-tailed t test (A, B, and C) or 1-way ANOVA (E, F, and G). *P < 0.05. **P < 0.01, ***P < 0.001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts